203 related articles for article (PubMed ID: 15178221)
1. HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
Watanabe A; Kawajiri M; Ikezoe K; Osoegawa M; Murai H; Ochi H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jun; 221(1-2):95-7. PubMed ID: 15178221
[TBL] [Abstract][Full Text] [Related]
2. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
4. HTLV-I-associated myelopathy (HAM/TSP) with Hashimoto's thyroiditis.
Kawai H; Kashiwagi S; Inui T; Tamaki Y; Sano Y; Saito S
Tokushima J Exp Med; 1991 Dec; 38(3-4):99-102. PubMed ID: 1843058
[TBL] [Abstract][Full Text] [Related]
5. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
6. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
7. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes.
Grindstaff P; Gruener G
Semin Neurol; 2005 Sep; 25(3):315-27. PubMed ID: 16170744
[TBL] [Abstract][Full Text] [Related]
8. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
[TBL] [Abstract][Full Text] [Related]
9. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
[TBL] [Abstract][Full Text] [Related]
10. HTLV-I associated myelopathy/tropical spastic paraparesis in a 7-year-old boy associated with infective dermatitis.
de Oliveira Mde F; Bittencourt AL; Brites C; Soares G; Hermes C; Almeida FO
J Neurol Sci; 2004 Jul; 222(1-2):35-8. PubMed ID: 15240193
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic primary biliary cirrhosis in HTLV-I-associated myelopathy.
Ijichi T; Miyata K; Mori S; Nakajima K; Okanoue T; Tsuchihashi Y
Am J Gastroenterol; 1993 Dec; 88(12):2107-9. PubMed ID: 8249982
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
14. [Chronic progressive cervical myelopathy with HTLV-I infection: variant form of HAM/TSP].
Umehara F
Rinsho Shinkeigaku; 2005 Nov; 45(11):916-8. PubMed ID: 16447762
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
Saito M; Usuku K; Arimura K; Izumo S; Osame M; Ohara Y
J Neurol Sci; 2008 Mar; 266(1-2):13-9. PubMed ID: 17884099
[TBL] [Abstract][Full Text] [Related]
16. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
17. [HTLV-I associated myelopathy (HAM) complicated with chronic polymyositis].
Tanaka T; Takagi A; Kojima S; Goto J; Tanaka M
Rinsho Shinkeigaku; 1989 Jan; 29(1):102-7. PubMed ID: 2743679
[TBL] [Abstract][Full Text] [Related]
18. [A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy].
Yanagihara C; Ihara M; Nishimura Y; Oka N
Rinsho Shinkeigaku; 1999 Sep; 39(9):971-5. PubMed ID: 10614165
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
[TBL] [Abstract][Full Text] [Related]
20. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
